They certainly look positive with significant statistical improvement and good safety profile. Most headlines are positive, but surprisingly Wall Street Journal leads with they fall short of earlier trial.
is the wall st. jo. talking about the same thing?
Results look good to me,also less side effects then competitors
Not to mentioned it is taken orally rather than injection.